Jim Simons Paratek Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.52 - $2.8 $171,152 - $315,280	-112,600 Reduced 46.51%	129,524 $286,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.54 $1,918 - $3,556	-1,400 Reduced 0.57%	242,124 $615,000
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.51 $24,549 - $36,897	14,700 Added 6.42%	243,524 $455,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $132,989 - $198,806	-67,852 Reduced 22.87%	228,824 $588,000
Q2 2022 Aug 12, 2022	BUY	$1.73 - $3.09 $213,225 - $380,848	123,252 Added 71.07%	296,676 $573,000
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $396,312 - $642,996	134,800 Added 349.01%	173,424 $515,000
Q4 2021 Feb 11, 2022	SELL	$4.07 - $5.3 $663,410 - $863,900	-163,000 Reduced 80.84%	38,624 $173,000
Q3 2021 Nov 12, 2021	SELL	$4.7 - $7.24 $1.07 Million - $1.64 Million	-226,800 Reduced 52.94%	201,624 $980,000
Q2 2021 Aug 13, 2021	SELL	$6.81 - $10.93 $1.19 Million - $1.92 Million	-175,396 Reduced 29.05%	428,424 $2.92 Million
Q1 2021 May 13, 2021	SELL	$6.14 - $8.31 $966,436 - $1.31 Million	-157,400 Reduced 20.68%	603,820 $4.26 Million
Q4 2020 Feb 10, 2021	BUY	$4.58 - $7.14 $1.01 Million - $1.57 Million	219,800 Added 40.6%	761,220 $4.77 Million
Q3 2020 Nov 13, 2020	BUY	$4.19 - $6.69 $297,121 - $474,401	70,912 Added 15.07%	541,420 $2.93 Million
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $1.4 Million - $2.46 Million	470,508 New	470,508 $2.46 Million
Q3 2019 Nov 13, 2019	SELL	$3.08 - $5.76 $385,458 - $720,858	-125,149 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$3.47 - $6.32 $564,569 - $1.03 Million	-162,700 Reduced 56.52%	125,149 $499,000
Q1 2019 May 14, 2019	SELL	$5.36 - $7.24 $312,600 - $422,244	-58,321 Reduced 16.85%	287,849 $1.54 Million
Q4 2018 Feb 13, 2019	BUY	$4.8 - $11.6 $1.66 Million - $4.02 Million	346,170 New	346,170 $1.78 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account